ABVC BIOPHARMA INC (ABVC)
US00091F3047 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.91M | -16.31M | -12.04M | -10.59M | -3.93M | |||
| Depreciation Amortization | 28.53K | 20.00K | 10.00K | 40.00K | 60.00K | |||
| Income Taxes - Deferred | 115.67K | 860.00K | 820.00K | -220.00K | -80.00K | |||
| Change In Working Capital | 735.29K | 640.00K | -1.61M | -90.00K | 600.00K | |||
| Interest Paid | 33.18K | 290.00K | 330.00K | 210.00K | 170.00K | |||
| Taxes Paid | 27.39K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 5.79M | 7.39M | 5.22M | 6.30M | 230.00K | |||
| OPERATING CASH FLOW | -4.24M | -7.40M | -7.60M | -4.56M | -3.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -21.20K | -120.00K | -20.00K | N/A | N/A | |||
| Other Investing Activity | -338.99K | -1.60M | -790.00K | -230.00K | -40.00K | |||
| INVESTING CASH FLOW | -360.19K | -1.72M | -810.00K | -230.00K | -40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 462.62K | 350.00K | -270.00K | 1.95M | 2.00M | |||
| Stock Issued/Repurchased | 3.46M | 3.66M | 11.12M | 7.62M | 1.08M | |||
| Other Financing Activity | N/A | 0.00 | -850.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 3.92M | 4.01M | 10.00M | 9.57M | 3.09M | |||
| Exchange Rate Effect | 2.12K | -70.00K | -30.00K | 60.00K | 0.00 | |||
| CHANGE IN CASH | -674.96K | -5.18M | 1.56M | 4.84M | -80.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.24M | -7.40M | -7.60M | -4.56M | -3.13M | |||
| Capital Expenditure | -21.20K | -120.00K | -20.00K | N/A | N/A | |||
| FREE CASH FLOW | -4.26M | -7.52M | -7.62M | -4.56M | -3.13M | |||
All data in USD